SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-033102
Filing Date
2023-09-19
Accepted
2023-09-19 17:25:05
Documents
7
Period of Report
2023-09-19

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 478182
2 formpre14a_001.jpg GRAPHIC 62403
3 formpre14a_002.jpg GRAPHIC 54954
4 formdef14a_001.jpg GRAPHIC 303290
5 formdef14a_002.jpg GRAPHIC 237305
6 proxy_001.jpg GRAPHIC 82626
7 proxy_002.jpg GRAPHIC 180691
  Complete submission text file 0001493152-23-033102.txt   1748666
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38022 | Film No.: 231264748
SIC: 2834 Pharmaceutical Preparations